- Vertex Stock Fell After a Setback on a New Drug. It’s an Opportunity for Investors. (Barron’s)
- Oil Jumps On Shocking OPEC+ Move As Saudis Brush Off Shale; ‘Drill, Baby, Drill Is Gone Forever’ (Investor’s Business Daily)
- Companies Are Issuing Guidance Again. What Investors Should Know. (Barron’s)
- Gasoline prices may hit highest levels since 2014 as OPEC+ keeps oil output cuts: report (MarketWatch)
- Walmart-Held Flipkart Reportedly Weighs U.S. Listing Through SPAC Deal (Barron’s)
- Oil Prices Spike on OPEC Surprise. How to Play It. (Barron’s)
- What’s next for markets, after the Fed’s Powell signals he’s not riding to the rescue just yet (MarketWatch)
- Rising Rates Hit M&A as CoStar Pulls Offer for CoreLogic (Barron’s)
- Amgen Acquires a Cancer Drug. Expect More Deals. (Barron’s)
- 5 reasons why negative repo rates are different than the last overnight-funding crisis (MarketWatch)
- ‘Coming 2 America’ Review: Comedic Royalty (New York Times)
- Here’s What’s in the Senate’s $1.9 Trillion Stimulus Legislation (Bloomberg)
- Boeing’s 737 Max Return Gathers Pace With 100 Planes Back in Sky (Bloomberg)
- A Country Club for Race Cars Emerges Minutes From Miami Beach (Bloomberg)
- Here’s why inflation is kryptonite for bonds as Powell’s comments rock markets (CNBC)
- Tech stocks’ market leadership may be over and investors aren’t ‘bullish enough about the reopening’, says Fundstrat’s Tom Lee (Business Insider)
- General Electric (GE) Catalyst Ahead on 3/10, PT Raised to ‘Street High’ $17 at Morgan Stanley (Street Insider)
- Connecticut Rolls Back Covid-19 Business Restrictions (Wall Street Journal)
- Apple Faces U.K. Antitrust Probe Over App Store Rules (Wall Street Journal)
- Winter Storm Eased Natural-Gas Glut (Wall Street Journal)